Site navigation

Navigation

Cardiovascular disease - statins

Statins for the prevention of cardiovascular events in patients at increased risk of developing cardiovascular disease or those with established cardiovascular disease

Summary

This guidance relates only to the initiation of statin therapy in adults with clinical evidence of cardiovascular disease (CVD) and in adults considered to be at risk of CVD. It assumes that other strategies for managing CVD risk are being appropriately considered when initiating statin therapy. The ...

Read the complete summary


A clinical guideline (CG67) on cardiovascular risk assessment has been published.


Guidance documents

Implementing this guidance

Other information

About this guidance

Technology appraisals TA94

Issued: January 2006

How this guidance was produced

See also:

See this guidance in practice:

Order printed copies of this guidance